![Gilberto Lopes: Press release just in time to make things more interesting for ASCO24](https://oncodaily.com/pub/uploads/2024/05/GILBERTO-de-lima-LOPES-Junior-2.jpg)
Photo of Gilberto Lopes from www.cancerletter.com
May 28, 2024, 08:31
Gilberto Lopes: Press release just in time to make things more interesting for ASCO24
Gilberto Lopes, Chief of the Division of Medical Oncology at Sylvester Comprehensive Cancer Center, shared a post on X:
”Press release just in time to make things more interesting for ASCO24 – Datopotamab deruxtecan showed ‘clinically meaningful’ overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial.”
Read further.
Source: Gilberto Lopes/X